You are here
Chaitan Khosla
Chaitan Khosla
Chaitan Khosla is Professor of Chemistry, Chemical Engineering, and, by courtesy, of Biochemistry at Stanford University. Over the past two decades, Dr. Khosla has studied polyketide synthases as paradigms for modular catalysis, and has exploited their properties for engineering novel antibiotics. More recently, he has investigated celiac sprue pathogenesis with the goal of developing drug therapies for this widespread but overlooked disease.
read more
He has co-authored over 200 publications, and is the recipient of several awards and honors including a National Science Foundation Young Investigator Award, a David and Lucile Packard Fellowship for Science and Engineering, the Allan P. Colburn Award from the American Institute of Chemical Engineers, the Eli Lilly Award in Biological Chemistry and the Pure Chemistry Award from the American Chemical Society, and the Alan T. Waterman Award from the National Science Foundation. He is also the recipient of a Distinguished Alumnus Award from his undergraduate and graduate alma maters.
Dr. Khosla is a founder of Kosan Biosciences, a public pharmaceutical company that develops polyketide drugs. He was also the founding president of the non-profit Celiac Sprue Research Foundation, and is a founder of Alvine Pharmaceuticals, a privately held company that develops drugs for celiac sprue. Dr. Khosla received a B.S. Tech. from the Indian Institute of Technology, Bombay, India and a Ph.D. from the California Institute of Technology. After completing postdoctoral studies at the John Innes Centre in the UK, he joined Stanford in 1992.